SLCO1A2 and breast carcinoma: Meyer zu Schwabedissen et al(59) also observed that the mRNA expression of OATP-1A2, a transporter capable of mediating the cellular uptake of estrogen metabolites, was ∼10-fold higher in breast cancer relative to adjacent healthy breast tissues.